International Journal of Infection

Published by: Kowsar

The Role of Antimicrobial-Impregnated Catheters on Catheter-Related Bloodstream Infection Prevention

Leonardo Lorente 1 , *
Author Information
1 Intensive Care Unit, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain
Article information
  • International Journal of Infection: October 1, 2015, 2 (4); e32568
  • Published Online: October 28, 2015
  • Article Type: Review Article
  • Received: August 19, 2015
  • Revised: August 24, 2015
  • Accepted: August 26, 2015
  • DOI: 10.17795/iji-32568

To Cite: Lorente L. The Role of Antimicrobial-Impregnated Catheters on Catheter-Related Bloodstream Infection Prevention, Int J Infect. 2015 ; 2(4):e32568. doi: 10.17795/iji-32568.

Abstract
Copyright © 2015, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
References
  • 1. Spengler RF, Greenough W3. Hospital costs and mortality attributed to nosocomial bacteremias. JAMA. 1978; 240(22): 2455-8[PubMed]
  • 2. Smith RL, Meixler SM, Simberkoff MS. Excess mortality in critically ill patients with nosocomial bloodstream infections. Chest. 1991; 100(1): 164-7[PubMed]
  • 3. Collignon PJ. Intravascular catheter associated sepsis: a common problem. The Australian Study on Intravascular Catheter Associated Sepsis. Med J Aust. 1994; 161(6): 374-8[PubMed]
  • 4. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1994; 271(20): 1598-601[PubMed]
  • 5. Haley RW, Schaberg DR, Crossley KB, Von Allmen SD, McGowan JJ. Extra charges and prolongation of stay attributable to nosocomial infections: a prospective interhospital comparison. Am J Med. 1981; 70(1): 51-8[PubMed]
  • 6. Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg. 2001; 136(2): 229-34[PubMed]
  • 7. Rello J, Ochagavia A, Sabanes E, Roque M, Mariscal D, Reynaga E, et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med. 2000; 162(3 Pt 1): 1027-30[DOI][PubMed]
  • 8. Arnow PM, Quimosing EM, Beach M. Consequences of intravascular catheter sepsis. Clin Infect Dis. 1993; 16(6): 778-84[PubMed]
  • 9. Lambert ML, Suetens C, Savey A, Palomar M, Hiesmayr M, Morales I, et al. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis. 2011; 11(1): 30-8[DOI][PubMed]
  • 10. O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011; 52(9)-93[DOI][PubMed]
  • 11. Ramritu P, Halton K, Collignon P, Cook D, Fraenkel D, Battistutta D, et al. A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units. Am J Infect Control. 2008; 36(2): 104-17[DOI][PubMed]
  • 12. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA. 1999; 281(3): 261-7[PubMed]
  • 13. Hockenhull JC, Dwan K, Boland A, Smith G, Bagust A, Dundar Y, et al. The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation. Health Technol Assess. 2008; 12(12)-1-154[PubMed]
  • 14. Brun-Buisson C, Doyon F, Sollet JP, Cochard JF, Cohen Y, Nitenberg G. Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial. Intensive Care Med. 2004; 30(5): 837-43[DOI][PubMed]
  • 15. Ostendorf T, Meinhold A, Harter C, Salwender H, Egerer G, Geiss HK, et al. Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients--a double-blind, randomised, prospective, controlled trial. Support Care Cancer. 2005; 13(12): 993-1000[DOI][PubMed]
  • 16. Rupp ME, Lisco SJ, Lipsett PA, Perl TM, Keating K, Civetta JM, et al. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med. 2005; 143(8): 570-80[PubMed]
  • 17. Falagas ME, Fragoulis K, Bliziotis IA, Chatzinikolaou I. Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2007; 59(3): 359-69[DOI][PubMed]
  • 18. Lorente L, Lecuona M, Ramos MJ, Jimenez A, Mora ML, Sierra A. The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia. Clin Infect Dis. 2008; 47(9): 1171-5[DOI][PubMed]
  • 19. Lorente L, Lecuona M, Ramos MJ, Jimenez A, Mora ML, Sierra A. Rifampicin-miconazole-impregnated catheters save cost in jugular venous sites with tracheostomy. Eur J Clin Microbiol Infect Dis. 2012; 31(8): 1833-6[DOI][PubMed]
  • 20. Lorente L, Lecuona M, Ramos MJ, Jimenez A, Mora ML, Sierra A. Lower associated costs using rifampicin-miconazoleimpregnated catheters compared with standard catheters. Am J Infect Control. 2011; 39(10): 895-7[DOI][PubMed]
  • 21. Lorente L, Henry C, Martin MM, Jimenez A, Mora ML. Central venous catheter-related infection in a prospective and observational study of 2,595 catheters. Crit Care. 2005; 9(6)-5[DOI][PubMed]
  • 22. Marik PE, Flemmer M, Harrison W. The risk of catheter-related bloodstream infection with femoral venous catheters as compared to subclavian and internal jugular venous catheters: a systematic review of the literature and meta-analysis. Crit Care Med. 2012; 40(8): 2479-85[DOI][PubMed]
  • 23. Nagashima G, Kikuchi T, Tsuyuzaki H, Kawano R, Tanaka H, Nemoto H, et al. To reduce catheter-related bloodstream infections: is the subclavian route better than the jugular route for central venous catheterization? J Infect Chemother. 2006; 12(6): 363-5[DOI][PubMed]
  • 24. Lorente L, Jimenez A. Central venous catheter site: should we really stop avoiding the femoral vein? Crit Care Med. 2013; 41(4)[DOI][PubMed]
  • 25. Lorente L, Jimenez A, Castedo J, Galvan R, Garcia C, Martin MM, et al. Internal jugular venous catheter-related bacteremia according to central and posterior accesses. Intensive Care Med. 2007; 33(6): 1071-5[DOI][PubMed]
  • 26. Coffin SE, Klompas M, Classen D, Arias KM, Podgorny K, Anderson DJ, et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infect Control Hosp Epidemiol. 2008; 29 Suppl 1-40[DOI][PubMed]
  • 27. Lorente L, Jimenez A, Garcia C, Galvan R, Castedo J, Martin MM, et al. Catheter-related bacteremia from femoral and central internal jugular venous access. Eur J Clin Microbiol Infect Dis. 2008; 27(9): 867-71[DOI][PubMed]
  • 28. Lorente L, Jimenez A, Galvan R, Garcia C, Castedo J, Martin MM, et al. Equivalence of posterior internal jugular and subclavian accesses in the incidence of central venous catheter related bacteremia. Intensive Care Med. 2007; 33(12): 2230-1[DOI][PubMed]
  • 29. Garnacho-Montero J, Aldabo-Pallas T, Palomar-Martinez M, Valles J, Almirante B, Garces R, et al. Risk factors and prognosis of catheter-related bloodstream infection in critically ill patients: a multicenter study. Intensive Care Med. 2008; 34(12): 2185-93[DOI][PubMed]
  • 30. Lorente L, Jimenez A, Martin MM, Castedo J, Galvan R, Garcia C, et al. Influence of tracheostomy on the incidence of central venous catheter-related bacteremia. Eur J Clin Microbiol Infect Dis. 2009; 28(9): 1141-5[DOI][PubMed]
  • 31. Lorente L, Jimenez A, Naranjo C, Martinez J, Iribarren JL, Jimenez JJ, et al. Higher incidence of catheter-related bacteremia in jugular site with tracheostomy than in femoral site. Infect Control Hosp Epidemiol. 2010; 31(3): 311-3[DOI][PubMed]
  • 32. Lorente L, Jimenez A, Martin MM, Palmero S, Jimenez JJ, Mora ML. Lower incidence of catheter-related bloodstream infection in subclavian venous access in the presence of tracheostomy than in femoral venous access: prospective observational study. Clin Microbiol Infect. 2011; 17(6): 870-2[DOI][PubMed]
  • 33. Lorente L, Jimenez A, Roca I, Martin MM, Mora ML. Influence of tracheostomy on the incidence of catheter-related bloodstream infection in the catheterization of jugular vein by posterior access. Eur J Clin Microbiol Infect Dis. 2011; 30(9): 1049-51[DOI][PubMed]
  • 34. Lorente L, Lecuona M, Jimenez A, Santacreu R, Raja L, Gonzalez O, et al. Chlorhexidine-silver sulfadiazine-impregnated venous catheters save costs. Am J Infect Control. 2014; 42(3): 321-4[DOI][PubMed]
  • 35. Lorente L, Lecuona M, Jimenez A, Lorenzo L, Diosdado S, Marca L, et al. Cost/benefit analysis of chlorhexidine-silver sulfadiazine-impregnated venous catheters for femoral access. Am J Infect Control. 2014; 42(10): 1130-2[DOI][PubMed]
  • 36. Lorente L, Lecuona M, Jimenez A, Lorenzo L, Santacreu R, Ramos S, et al. Efficiency of chlorhexidine-silver sulfadiazine-impregnated venous catheters at subclavian sites. Am J Infect Control. 2015; 43(7): 711-4[DOI][PubMed]
  • 37. Pai MP, Pendland SL, Danziger LH. Antimicrobial-coated/bonded and -impregnated intravascular catheters. Ann Pharmacother. 2001; 35(10): 1255-63[PubMed]
  • 38. Saint S, Veenstra DL, Lipsky BA. The clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheters useful? Infect Control Hosp Epidemiol. 2000; 21(6): 375-80[DOI][PubMed]
  • 39. Darouiche RO, Raad ,I, Heard SO, Thornby JI, Wenker OC, Gabrielli A, et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med. 1999; 340(1): 1-8[DOI][PubMed]
  • 40. Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med. 1997; 127(4): 267-74[PubMed]
  • 41. Hanna H, Benjamin R, Chatzinikolaou I, Alakech B, Richardson D, Mansfield P, et al. Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial. J Clin Oncol. 2004; 22(15): 3163-71[DOI][PubMed]
  • 42. Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006; 355(26): 2725-32[DOI][PubMed]
  • 43. Palomar M, Alvarez-Lerma F, Riera A, Diaz MT, Torres F, Agra Y, et al. Impact of a national multimodal intervention to prevent catheter-related bloodstream infection in the ICU: the Spanish experience. Crit Care Med. 2013; 41(10): 2364-72[DOI][PubMed]
  • 44. Miller MR, Griswold M, Harris J2, Yenokyan G, Huskins WC, Moss M, et al. Decreasing PICU catheter-associated bloodstream infections: NACHRI's quality transformation efforts. Pediatrics. 2010; 125(2): 206-13[DOI][PubMed]
  • 45. Warren DK, Cosgrove SE, Diekema DJ, Zuccotti G, Climo MW, Bolon MK, et al. A multicenter intervention to prevent catheter-associated bloodstream infections. Infect Control Hosp Epidemiol. 2006; 27(7): 662-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments